Search

Your search keyword '"Yoo, Sarah"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Yoo, Sarah" Remove constraint Author: "Yoo, Sarah"
29 results on '"Yoo, Sarah"'

Search Results

1. GPT-4 Technical Report

2. Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites

4. Developing a membrane-proximal CD33-targeting CAR T cell

5. Preclinical Evaluation of Chimeric Antigen Receptor-Modified Natural Killer Cells Targeting Membrane-Proximal CD33 in Acute Myelogenous Leukemia

6. CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma

10. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival

13. Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma

14. Vitamin D receptor polymorphisms in patients with cutaneous melanoma

15. Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma

16. Prediction of toxicity in R/R DLBCL treated with Axicabtagene Clioleucel (19-28z CAR T)

17. Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

18. Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

19. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the agricultural health study

21. Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL).

22. CD19-Targeted 19-28z CAR Modified Autologous T Cells Induce High Rates of Complete Remission and Durable Responses in Adult Patients with Relapsed, Refractory B-Cell ALL

23. Interim Safety Analysis: a Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed By Infusion of Chimeric Antigen Receptor Modified T-Cells (19-28z CAR-T) Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma (B-NHL)

25. Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy

28. Sun Exposure, Vitamin D Receptor Genetic Variants, and Risk of Breast Cancer in the Agricultural Health Study

29. Augmenting CAR T Cell Functions with LIGHT.

Catalog

Books, media, physical & digital resources